Met-enkephalin at doses too low for pain relief specifically blocked the aversive behavior caused by substance P — showing it can selectively modulate pain signaling.
Aversion blocked without analgesiaAt doses too low for direct pain relief
What the researchers found
Intrathecal (spinal cord) met-enkephalin at low doses markedly reduced the aversive behavior caused by intrathecal substance P. At these same low doses, met-enkephalin produced no measurable analgesia in the tail-flick pain test.
Met-enkephalin needed much higher doses to produce general analgesia.
Beta-endorphin and dynorphin-(1-17) were different. They blocked substance P-induced behavior and produced general analgesia at roughly the same doses. There was no separation between the two effects.
This suggests met-enkephalin has a specific, preferential interaction with substance P-mediated pain signaling in the spinal cord, separate from its general painkilling effects.
Why it matters
Substance P is one of the main pain neurotransmitters in the spinal cord. Finding that met-enkephalin specifically counteracts substance P at very low doses suggests a targeted interaction between the enkephalin and substance P systems. This could inform development of spinal pain treatments.
How the study worked
Mice received intrathecal injections of substance P (to cause aversive behavior) followed by intrathecal met-enkephalin, beta-endorphin, or dynorphin. Aversive behavior was scored. General pain relief was measured by tail-flick test. Multiple doses tested for each peptide.
What this study cannot tell us
Tested in mice, not people. Intrathecal injection is an invasive route not commonly used clinically. Only one aversive behavior model was tested. The mechanism of enkephalin-substance P interaction was not identified.
How to read the evidence
Preliminary animal study with elegant dose separation but limited to one behavioral model.
When this study was published
Published in 1988 — early evidence for dissociable pain components modulated by opioid peptides.
The bigger picture
Pain has both sensory and emotional components. This study showed enkephalin can selectively target the emotional/aversive component at low doses, potentially enabling more targeted pain treatment.
Questions still open
- Could low-dose enkephalin treat pain suffering without complete anesthesia?
- Does this selectivity translate to clinical pain management?
Common questions
What is substance P?
Why is blocking aversion without analgesia useful?
Read the original research
Enkephalins interact with substance P-induced aversive behaviour in mice.
Brain research, 442(1), 191-4
Citation
Sakurada, T; Takahashi, K; Sakurada, S; Kisara, K; Folkesson, R; Terenius, L. (1988). Enkephalins interact with substance P-induced aversive behaviour in mice.. Brain research, 442(1), 191-4.